0
Skip to Content
Innovimmune Biotherapeutics
Platform
About
About Us
Management
Scientific Advisory Board
Pipeline
Our Pipeline
INV-25 LXR Agonist
INV-88 MIF Inhibitor
INV-17 ROR Gamma Inverse Agonist
INV-71 ROR Gamma Agonist
Media
News
Events
Contact
Partner with us
Innovimmune Biotherapeutics
Platform
About
About Us
Management
Scientific Advisory Board
Pipeline
Our Pipeline
INV-25 LXR Agonist
INV-88 MIF Inhibitor
INV-17 ROR Gamma Inverse Agonist
INV-71 ROR Gamma Agonist
Media
News
Events
Contact
Partner with us
Platform
Folder: About
Back
About Us
Management
Scientific Advisory Board
Folder: Pipeline
Back
Our Pipeline
INV-25 LXR Agonist
INV-88 MIF Inhibitor
INV-17 ROR Gamma Inverse Agonist
INV-71 ROR Gamma Agonist
Folder: Media
Back
News
Events
Contact
Partner with us

 Our Management

 

John Ellingboe, Ph.D.

Vice President, Discovery Sciences

 

Anderson Gaweco, M.D., Ph.D.

Chief Executive Officer

 

Jefferson Tilley, Ph.D.

Vice President, Discovery Chemistry

 

William T. Windsor, Ph.D.

Vice President, Discovery Biology

 

Partnering, advancing together

We are seeking strategic partnerships with pharmaceutical and biotechnology companies to advance Innovimmune’s novel therapeutic discoveries and accelerate R&D through clinical development, approval and commercialization.

Get in touch

INNOVIMMUNE
75 Wall Street, New York,
New York 10005, USA

Copyright © 2024 INNOVIMMUNE

Get in touch

Media Inquiries
media@innovimmune.com

Partnering & Licensing Inquiries
partnering@innovimmune.com